ORG-25935

DB12220InvestigationalSmall molecule

Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

Mechanism: Pharmacologically active on Sodium- and chloride-dependent glycine transporter 1
Curator reviewed
Formula / weight: C₂₁H₂₅NO₃ · 339.435 g/mol (avg)
Code names: ORG 25935 · SCH-900435

Resolves to

Compound

Structure

InChIKeyUEBBYLJZCHTLEG-UTKZUKDTSA-NSMILESCOC1=CC=C2[C@H]([C@@H](CN(C)CC(O)=O)CCC2=C1)C1=CC=CC=C1

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

5Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with ORG-25935, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.